FDA Adverse Event Injury Summary report: N

GMK-SPHERE TIBIAL INSERT FIXED SPHERE FLEX SIZE 2/11 MM L

MDR report key: 18985055 · Received March 27, 2024

Report

Report Number
3005180920-2024-00185
Event Type
Injury
Date Received
March 27, 2024
Date of Event
March 1, 2024
Report Date
March 27, 2024
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030862526
PMA / PMN Number
K140826
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 27-MAR-2024: LOT 2201026: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 05-APR-2022. EXPIRATION DATE: 2027-03-24. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ADDITIONAL IMPLANTS INVOLVED, BATCH REVIEW PERFORMED ON 27-MAR-2024: GMK-SPHERE 02.12.0022L FEMORAL COMPONENT SPHERE CEMENTED SIZE 2+ L (K140826) LOT 2204931: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 25-MAY-2022. EXPIRATION DATE: 2027-05-11. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. GMK-SPHERE 02.07.1202L TIBIAL TRAY FIXED CEMENTED SIZE 2 L (K090988) LOT 2202592: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 13-JUN-2022. EXPIRATION DATE: 2027-05-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL THE ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

AT ABOUT 3 MONTHS AFTER PRIMARY, THE PATIENT HAS BEEN REVISED BECAUSE OF INFECTION AND THE CAUSE IS UNKNOWN. THE SURGEON REMOVED ALL COMPONENTS AND INSERTED CEMENT MOLD. THE SURGERY WAS COMPLETED SUCCESSFULLY. THE DELAY TIME WAS 10MIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
527128 GMK-SPHERE TIBIAL INSERT FIXED SPHERE FLEX SIZE 2/11 MM L KNEE TIBIAL INSERT JWH MEDACTA INTERNATIONAL SA 2201026 07630030862526

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention